Table 3.
Parameter | Index surgical procedure | p | ||||
---|---|---|---|---|---|---|
Definitive fusion | Growth sparing | |||||
N | Mean (range) | N | Mean (range) | |||
Preoperative | Major curve cobb | 21 | 73 (47–105) | 18 | 77 (47–131) | 0.6 |
T1-12 height (mm) | 21 | 166 (126–215) | 18 | 164 (114–201) | 0.8 | |
T1-S1 length (mm) | 21 | 292 (221–354) | 18 | 279 (205–341) | 0.3 | |
Max kyphosis | 20 | 48 (5–81) | 18 | 43 (15–75) | 0.4 | |
Age at surgery (years) | 21 | 9.1 (6.1–10.9) | 18 | 7.9 (6.3–10) | 0.003 | |
Curve levels | 21 | 12 (5–15) | 18 | 13.4 (10–17) | 0.2 | |
Radiographic follow-up | Age (years) | 21 | 14.5 (11.1–17.8) | 18 | 14.3 (11–19.6) | 0.8 |
Time since surgery (months) | 21 | 63 (26–101) | 18 | 76 (40–138) | 0.2 | |
Major curve cobb | 21 | 32 (4–76) | 18 | 32 (13–60) | 0.9 | |
T1-12 height (mm) | 21 | 199 (156–241) | 18 | 211 (156–262) | 0.2 | |
T1-S1 length (mm) | 21 | 340 (271–446) | 18 | 354 (289–428) | 0.3 | |
Max kyphosis | 21 | 37 (9–55) | 18 | 36 (7–58) | 1.0 | |
Instrumented levels | 21 | 12.8 (5–18) | 18 | 14.2 (11–16) | 0.1 | |
Additional surgeries | 21 | 0.6 (0–4) | 18 | 3.3 (1–11) | < 0.001 | |
PFT follow-up | Age (years) | 21 | 13.6 (10.7–17.8) | 18 | 12.6 (9.5–15.8) | 0.1 |
Time since surgery (months) | 21 | 53 (26.7–84.9) | 18 | 56 (30–106) | 0.7 | |
FVC actual | 21 | 1.9 (0.5–6) | 18 | 1.7 (0.3–3.4) | 0.4 | |
FVC percent predicted | 21 | 58 (15–158) | 18 | 50 (14–74) | 0.3 | |
FEV1 actual | 21 | 1.4 (0.5–2.3) | 18 | 1.4 (0.3–2.3) | 0.6 | |
FEV1 percent predicted | 21 | 51 (16–77) | 18 | 48 (14–70) | 0.5 | |
Changes at follow-up | % Correction major curve cobb | 54 (− 29 to 94) | 55 (-13–82) | 0.9 | ||
Change in T1-12 height (mm) | 33 (− 6 to 76) | 47 (18–100) | 0.1 | |||
Change in T1-S1 length (mm) | 48 (11–118) | 74 (43–125) | 0.002 | |||
Change in levels | 1 (0–7) | 1 (− 2 to 7) | 0.9 | |||
ΔFVC actual | 0.7 (0.1–1.7) | 0.7 (0.6–0.9) | 0.7 | |||
ΔFVC % predicted | − 3.9 (− 63–54) | − 7.8 (− 32 to 11) | 0.7 | |||
ΔFEV1 actual | 0.5 (0.1–1.2) | 0.5 (0.3–0.7) | 1.0 | |||
ΔFEV1% predicted | − 2.6 (− 24–39) | − 12.1 (− 40 to 4) | 0.2 |